From Clinicaltrials.gov:

"This (Kevetrin) trial will determine tolerance in human, and, POSSIBLY EFFICACY with a Phase 1, open label, dose-escalation . . . of Kevetrin in adult patients with solid tumors."

Kevetrin, not your "father's" buick . . .